# Rituximab versus the modified Ponticelli regimen in the treatment of primary membranous nephropathy: a Health Economic Model

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rituximab-versus-the-modified-ponticelli-regimen-in-the-treatment-of-primary/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Patrick Hamilton,Durga Kanigicherla,Michael Venning,Paul Brenchley,David Meads |
| Citations | 25 |
| DOI | 10.1093/ndt/gfy049 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/ndt/article-pdf/33/12/2145/26757429/gfy049.pdf |
| OpenAlex ID | https://openalex.org/W2794975738 |
| PMID | 29617884 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Durga Kanigicherla](https://scholariq.org/researchers/durga-kanigicherla/)

## Paper journal

- [Nephrology Dialysis Transplantation](https://scholariq.org/journals/nephrology-dialysis-transplantation/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.